The Pfizer-BioNTech COVID-19 vaccine became the first vaccine to receive the World Health Organisation (WHO) validation for emergency use since the pandemic outbreak.
“Regulatory experts from around the world reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy and quality. They found that the vaccine met the must-have criteria for safety, efficacy and that the benefits of using it to address the disease offset potential risks,” WHO Tweeted.
The Pfizer/BioNTech #COVID19 vaccine today became the first vaccine to receive WHO validation for emergency use since the outbreak began.
— World Health Organization (WHO) (@WHO) December 31, 2020
Equitable global access to vaccines is crucial to combat the pandemic.
👉 https://t.co/7WNcHhc3z8 pic.twitter.com/Kyjv5RNzjB
Regulatory experts from around the 🌐 reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy & quality. They found that the vaccine met the must-have criteria for safety & efficacy & that the benefits of using it to address the disease offset potential risks pic.twitter.com/XSCQIDlw9b
— World Health Organization (WHO) (@WHO) December 31, 2020
India caps airline fares as IndiGo crisis leaves hundreds stranded for fifth day
Putin and Modi discuss trade, peace in New Delhi summit
Indian air travel crippled as IndiGo's pilot crisis enters fourth day
Lebanon says ceasefire talks aim primarily at halting Israel's hostilities
US to widen travel ban to more than 30 countries, Noem says
